Doctor profile · Federal record
Dr. Neel Dharia, MD
Hematology & Oncology Physician (CMS: Medical Oncology) · Mesa, AZ
- NPI 1760458103
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1432 S Dobson RD, 106
Mesa, AZ 852024768
(480) 969-3637
fax (480) 969-6568 - Mailing address
-
Po Box 6423
Chandler, AZ 852466423
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- November 30, 2022
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #31818
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760458103. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
94,509
Distinct HCPCS
10
Medicare allowed
$1,108,018
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 41,160 | 24 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 18,900 | 11 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,313 | 14 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,650 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,580 | 19 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,420 | 46 | $0 | |
J0640 |
Injection, leucovorin calcium, per 50 mg | 1,656 | 19 | $4 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,570 | 36 | $1 | |
J0461 |
Injection, atropine sulfate, 0.01 mg | 1,400 | 11 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,213 | 424 | $87 |
In context: peer comparison
Among 3 peers in Mesa Hematology & Oncology Physician, average services per provider: 1,776. This provider delivers 53× the peer median.Open Payments
Industry payments received
All-time total
$11,954
Transactions
166
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo INC. | 13 | $2,953.19 | |
| Ipsen Biopharmaceuticals, INC | 2 | $1,883.25 | |
| AstraZeneca Pharmaceuticals Lp | 12 | $1,822.04 | |
| Pfizer INC. | 21 | $1,589.65 | |
| Novartis Pharmaceuticals Corporation | 16 | $319.61 | |
| Abbvie INC. | 16 | $259.02 | |
| Regeneron Healthcare Solutions, INC. | 6 | $257.78 | |
| Merck Sharp & Dohme LLC | 12 | $238.73 | |
| E.R. Squibb & Sons, L.L.C. | 12 | $214.62 | |
| Celgene Corporation | 19 | $199.44 | |
| Genzyme Corporation | 6 | $166.53 | |
| GlaxoSmithKline, LLC. | 11 | $163.37 | |
| Eisai INC. | 6 | $159.97 | |
| Janssen Biotech, INC. | 8 | $134.41 | |
| Astellas Pharma US INC | 6 | $120.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
967
Patients
315
Total drug cost
$1,311,099
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 162 | 43 | $4,153 |
| Eliquis (Apixaban) | Brand | 157 | 34 | $112,768 |
| Acyclovir | Generic | 72 | 20 | $1,817 |
| Dexamethasone | Generic | 71 | 42 | $1,361 |
| Oxycodone Hcl | Generic | 69 | 25 | $1,077 |
| Ondansetron Odt (Ondansetron) | Brand | 67 | 47 | $1,191 |
| Prochlorperazine Maleate | Generic | 63 | 42 | $1,372 |
| Letrozole | Generic | 46 | 15 | $1,418 |
| Prednisone | Generic | 44 | 20 | $459 |
| Xarelto (Rivaroxaban) | Brand | 44 | 11 | $36,109 |
Hospital affiliations
Frequently asked questions
What is Dr. Neel Dharia's medical specialty?
Dr. Neel Dharia practices Hematology & Oncology Physician in Mesa, AZ.
Where does Dr. Neel Dharia practice?
Dr. Neel Dharia practices at 1432 S Dobson RD, Mesa, AZ 852024768. Office phone: 4809693637.
What is Dr. Neel Dharia's NPI?
Dr. Neel Dharia's National Provider Identifier (NPI) is 1760458103, issued by NPPES.
Does Dr. Neel Dharia accept Medicare assignment?
Yes. Dr. Neel Dharia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Neel Dharia commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.